Biosciences research building
The University of Arizona (UA) College of Medicine in Phoenix, Arizona, US, broke ground on a new research facility named Biosciences Partnership Building on the Phoenix Biomedical Campus, a major bioresearch and education hub in downtown Phoenix in October 2014.
Construction of the new research building, located immediately north of the UA’s existing Health Sciences Education building in Phoenix Biomedical Campus, near 7th Street and Fillmore was completed in early 2017.
The construction was sponsored by the UA and the city of Phoenix. Biomedical research is housed in the building, as well as laboratory facilities to conduct research into partnerships with industries on key medical areas such as neuroscience, cardiovascular and thoracic science.
The project created 500 jobs during construction and currently employs 360 permanent staff.
The facility is the first antibiotic-free and animal-free cell culture media and supplements manufacturing facility in the pharmaceutical industry.
Construction of the biosciences building was approved by the Arizona Legislature’s Joint Committee on Capital Review in 2010.
The ten-storey, 245,000ft² building expanded research facilities at the UA Medical Campus, while paving the way for innovative therapeutic discoveries to improve lives. The research focuses on neurosciences, healthcare outcomes, cancer and precision medicine.
The research facility provides faculty to teach the next generation of health professionals. It creates employment opportunities in the field of research, while providing opportunities to specialised technicians and other support staff.
Biosciences Partnership Building is part of a larger expansion project underway at the Phoenix Biomedical Campus.
In 2012, the Health Sciences Education Building was opened at the campus and a new 220,000ft² cancer centre at Dignity Health St. Joseph’s was opened in 2015.
Additionally, the Phoenix Biomedical Campus already houses four health science colleges including the Mel and Enid Zuckerman College of Public Health, and the colleges for nursing and pharmacy.
Arizona State University’s School of Nutrition and Health Innovation is located in the Arizona Biomedical Collaborative 1 building. Plans are in place to build another building between the Arizona Biosciences College (ABCI) and Translational Genomics Research Institute.
Total investment for the construction of the Biosciences Partnership Building is $136m. The funding is from the stimulus plan for Economic and Educational Development bonds approved by the Arizona legislature in 2008, for the construction of the Health Sciences Education Building and campus improvements.
California-based CO Architects and Ayers Saint Gross of Phoenix designed the biosciences building. A joint venture of DPR Construction and Sundt Construction are the construction managers for the research building project.
The aim of the state of Arizona and city of Phoenix is to develop PBC as a major biosciences hub and premier academic health centre in the region. Once fully developed, the campus creates an economic impact of up to $2bn every year.
Including the Biosciences Partnership Building, the PBC is spread across 28 acres with various bioscience and education projects. Plans are in place for the construction of more than six million square feet of biomedical-related research, academic and clinical facilities.
Phoenix Biomedical campus follows the environmental sustainability policies set by the UA and Northern Arizona University (NAU). An internal team known as PBC Green Team was formed in August 2009 to understand local sustainability practices, define the framework for a campus sustainability plan, periodically assess the sustainability efforts on the campus and suggest improvements and initiatives.
Sustainability initiatives adopted on the campus include recycling of light ballasts, paper, cardboard, glass bottles and aluminium cans, use of sustainability products, energy-efficient fixtures and systems, as well as waste reduction programmes.
Lonza announced the expansion of its bioconjugation facility at its Visp site in Switzerland in December 2020. The expansion will…
Thermo Fisher Scientific (Thermo Fisher) will establish a new pharmaceutical services facility for integrated biologics and sterile drug development and…
Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020. The…
Merck announced the expansion of its high-potent active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) production capabilities and capacity at…